Pharmacolog signs distribution agreement with B. Braun Portugal
Pharmacolog i Uppsala AB (publ) and B. Braun extend existing agreement to include sales of DrugLog™ and PrepLog™ with associated services in Portugal.
Pharmacolog announces the signing of an extension of the distribution agreement with B. Braun to include sales in Portugal. The extension of the agreement is a direct result of a successful collaboration with B. Braun in Spain where DrugLog™ systems are in use at multiple hospital pharmacies.
DrugLog™ enables hospital pharmacies to implement additional quality control by verifying the identity and concentration of compounded injectable medications to ensure each drug is prepared accurately and safely prior to administration to a patient. Used as part of the pharmacy’s in-house quality control process, DrugLog™ is ideal for chemotherapy and compounded medications whether patient-specific or batch produced.
Lars Gusch, CEO of Pharmacolog comments: “Extending the agreement with B. Braun to include sales in Portugal is in line with our strategy to broaden the distribution network. We are very pleased to open another market opportunity and reinforce our long-term collaboration with B. Braun.”
Pharmacolog provides solutions and products that enhance work efficiency and safety when preparing injectable medication. Our goal is to help prevent medication errors and ensure maximum medication efficacy when treating patients with powerful yet potentially harmful injectable drugs. Pharmacolog’s products help staff at pharmacies and hospital wards minimize the risk of errors in the compounding process. Furthermore, by verifying that drugs and narcotics used in surgery have not been tampered with, our solutions also make a vital contribution to preventing drug diversion.